KNG1 and angioedema: Drugs, particularly angiotensin-converting enzyme inhibitors (ACEi) and less frequently angiotensin II receptor antagonists (ARA-II), dipeptidyl peptidase 4 (DPP-IV) inhibitors and sacubitril, involved in kinin degradation, have been associated with bradykinin-mediated angioedema (29).